Nosopharm
Nosopharm is a healthcare company, headquartered in France.
Entry
2019
Hold
4yr
Exit
2023
Est. EV
–
Who owns Nosopharm?
Nosopharm was owned by UI Investissement through Pertinence Invest 3 (PI3) (2026 vintage) from 2019 to 2023.
Hand-verified · updated 2026-04-21
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2023
More from Pertinence Invest 3 (PI3)
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Data refreshed weekly · Sourced from public filings